To test this hypothesis, we characterized muscle SOCS3 expression in response to metabolic challenges known to be associated with insulin and/or leptin resistance such as high-fat diet feeding, genetic obesity, lipid infusion, and TNFα injection. The gene discussed is SOCS3; the disease is obesity disorder.